Contact Us

MEETING NEWS

Actinogen announces new and unique nonproprietary name of 'emestedastat' for Xanamem

Feb 7, 2025

Late-stage Alzheimer\'s trial opens 10 new sites in USA,with results due in 2025 and 2026 SYDNEY,Feb. 5,2025-- Actinogen Medical Limited (ASX: ACW) announces that the World Health Organization (WHO)

Akeso Announces the Completion of Patient Enrollment in the Phase III Clinical Trial (HARMONi-6) Comparing Ivonescimab and Tislelizumab for First-Line Treatment of Sq-NSCLC

Feb 7, 2025

HONG KONG,Feb. 6,2025--Akeso,Inc. (9926.HK) ("Akeso" or the "Company")is excited to announce the completion of patient enrollment in the global Phase III clinical trial (HARMONi-6/

GCCL Applauded by Frost & Sullivan for Ensuring Consistent, Reliable Clinical Trial Data in APAC

Feb 7, 2025

GCCL is committed to customer success,emphasizing quality control at every stage—from analysis consulting and sample processing to data management—ensuring efficient clinical trials and research an

Transforming Entertainment with AI: Vyin AI Redefines Hyper-Personalized Interactions

Feb 7, 2025

TAIPEI,Feb. 6,2025-- Vyin AI,an artificial intelligence brand under Gamania Group,is breaking new ground by seamlessly integrating AI with celebrity IP to revolutionize the entertainment landscape. It

Dubai Fountain Undergoes a Stunning Revamp: Temporary Closure Announced for Upgrade and Enhancement

Feb 7, 2025

Starting in May,the iconic attraction will be closed for five months DUBAI,UAE,Feb. 6,2025-- Emaar has announced the temporary closure of Dubai Fountain,the world\'s largest performing fountain,locate

KT&G Successfully Improves Profitability in First Year of New Leadership, Promises Active Shareholder Returns

Feb 7, 2025

New CEO\'s fundamental competitiveness improvement and financial structure optimization leads to parallel growth of full-year revenue and operating profit

1 ... 95 96 97 98 99 100 101 ... 336